VION Biosciences Acquires Ansh Labs
August 29, 2024
VION Biosciences, the life-science platform backed by Iron Path Capital, has acquired Ansh Labs, an immunoassay development and reagent manufacturer based in Houston, Texas. The add-on expands VION's diagnostics capabilities — adding GMP IVD manufacturing and ISO 13485 certification — and broadens the platform's product and service offerings for clinical diagnostics, research, and pharmaceutical development.
- Buyers
- VION Biosciences, Iron Path Capital
- Targets
- Ansh Labs
- Platforms
- VION Biosciences
- Industry
- Biotechnology
- Location
- Texas, United States
- Transaction Type
- Addon
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.